Вопросы рационального использования противотуберкулезных лекарственных препаратов

Яблонский Петр Казимирович, Айзиков Дмитрий Львович, Кечаева Надежда Викторовна et al. · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · 2011

This article reflects planning of the medicine needs in subjects of the Russian Federation included in the Ural Federal Region. Data of statistical report forms and specially developed in St.-Petersburg RIPP forms in which the number of persons planned to treatment by means of different regimes of chemotherapy are indicated. On basis of these data the planned needs for anti-TB drugs are calculated. There are cases of planning of the continuation phase of the second B chemotherapy regimen. It is found that test therapy in the structure of administrations will take 13,8 % the duration of test therapy, compared with chemoprophylaxis and anti-relapse treatment will be less prolonged, but its cost will exceed the cost of the intensive phase of the first chemotherapy regimen for the planned number of patients. Analysis of the statistical forms showed that the economic inefficiency of test therapy achieved 69,5 % in adult population and 70,6 % among children (in some cases, clinical and economic expenditures accounted for 96,9 %). When saving the existing approaches to administration of anti-TB drugs for test therapy annually are planned economic losses, which are comparable to the cost of the first chemotherapy regimen. With a balanced approach to test treatment administration it becomes possible to direct the released economic resources for introduction and use of highly sensitive and highly specific methods of TB diagnosis, allowing to reduce the frequency of test treatment administration

Cited by 0 works.

Authors